Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Renal AA amyloidosis revealing extramedullary plasmocytoma
CONCLUSION: Extramedullary plasmacytoma is a rare tumour that may be associated with amyloidosis, usually type AL. To our knowledge, its association with AA amyloidosis has not been reported in the literature. Treatment is based on surgery combined with radiotherapy or chemotherapy.PMID:38073243 | DOI:10.1684/ndt.2023.54 (Source: Nephrologie and Therapeutique)
Source: Nephrologie and Therapeutique - December 11, 2023 Category: Urology & Nephrology Authors: Amel Harzallah Hanen Abid Meriam Hajji Sahar Agrebi Fethi Ben Hamida Soumaya Chargui Ezzedine Abderrahim Source Type: research
Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy
CONCLUSIONS: Patients with RT-refractory SPs can achieve good local control with alternative therapies such as surgery or systemic therapy if needed. Additional RT dose not seem to be effective. Given the known high rates of progression from SP to multiple myeloma, close observation of asymptomatic persistent disease until disease progression is likely sufficient in most cases.PMID:38070713 | DOI:10.1016/j.ijrobp.2023.11.039 (Source: Cancer Control)
Source: Cancer Control - December 9, 2023 Category: Cancer & Oncology Authors: Penny Fang Chelsea C Pinnix Susan Y Wu Hans C Lee Krina K Patel Neeraj Saini Melody R Becnel Gregory Kaufman Sheeba K Thomas Robert Z Orlowski Behrang Amini Pei Lin Bouthaina S Dabaja Jillian R Gunther Source Type: research
Prevalence and interpretation of AFF immunostain of DEK::AFF2 fusion-associated papillary squamous cell carcinoma in a retrospective cohort of recurrent sinonasal papillomas
In this study, AFF immunohistochemistry (IHC) was performed in recurrent sinonasal papillomas for reviewing the prevalence of undiagnosedDEK::AFF2 carcinomas and to investigate the performance of AFF IHC in diagnosis ofDEK::AFF2 carcinomas. Recurrent sinonasal papillomas after surgical excision in a two-decade period were retrieved. Histologic slides were reviewed for features ofDEK::AFF2 carcinoma. AFF IHC was performed, and cases with any (> 1%) nuclear positivity were validated byDEK break apart fluorescence in situ hybridization. Totally 43 cases were included, comprising 28 inverted, 6 exophytic, one oncocytic, ...
Source: Virchows Archiv - December 8, 2023 Category: Pathology Source Type: research
Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy
We examined outcomes after early systemic therapy, surgical resection or observation for patients with RT-refractory disease and assessed potential impact of treatment selection on disease outcomes. (Source: International Journal of Radiation Oncology * Biology * Physics)
Source: International Journal of Radiation Oncology * Biology * Physics - December 7, 2023 Category: Radiology Authors: Penny Fang, Chelsea C. Pinnix, Susan Y. Wu, Hans C. Lee, Krina K. Patel, Neeraj Saini, Melody R. Becnel, Gregory Kaufman, Sheeba K. Thomas, Robert Z. Orlowski, Behrang Amini, Pei Lin, Bouthaina S. Dabaja, Jillian R. Gunther Tags: Brief Report Source Type: research
Exploring the lncRNA-VEGF axis: Implications for cancer detection and therapy
Pathol Res Pract. 2023 Nov 29;253:154998. doi: 10.1016/j.prp.2023.154998. Online ahead of print.ABSTRACTCancer is a complicated illness that spreads indefinitely owing to epigenetic, genetic, and genomic alterations. Cancer cell multidrug susceptibility represents a severe barrier in cancer therapy. As a result, creating effective therapies requires a better knowledge of the mechanisms driving cancer development, progress, and resistance to medications. The human genome is predominantly made up of long non coding RNAs (lncRNAs), which are currently identified as critical moderators in a variety of biological functions. Rec...
Source: Pathology, Research and Practice - December 6, 2023 Category: Pathology Authors: Nahed S Alharthi Maryam Hassan Al-Zahrani Ali Hazazi Hayaa Moeed Alhuthali Amal F Gharib Shatha Alzahrani Wafa Altalhi Waleed Hassan Almalki Farhan R Khan Source Type: research
